11-6498331-A-G
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBS1BS2
The NM_144666.3(DNHD1):āc.116A>Gā(p.Gln39Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00134 in 1,614,246 control chromosomes in the GnomAD database, including 9 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Consequence
NM_144666.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -19 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DNHD1 | NM_144666.3 | c.116A>G | p.Gln39Arg | missense_variant | 3/43 | ENST00000254579.11 | NP_653267.2 | |
DNHD1 | NM_173589.4 | c.116A>G | p.Gln39Arg | missense_variant | 2/8 | NP_775860.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNHD1 | ENST00000254579.11 | c.116A>G | p.Gln39Arg | missense_variant | 3/43 | 5 | NM_144666.3 | ENSP00000254579.6 |
Frequencies
GnomAD3 genomes AF: 0.000952 AC: 145AN: 152234Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00204 AC: 513AN: 251318Hom.: 3 AF XY: 0.00235 AC XY: 319AN XY: 135828
GnomAD4 exome AF: 0.00139 AC: 2025AN: 1461894Hom.: 9 Cov.: 33 AF XY: 0.00157 AC XY: 1139AN XY: 727248
GnomAD4 genome AF: 0.000952 AC: 145AN: 152352Hom.: 0 Cov.: 33 AF XY: 0.00106 AC XY: 79AN XY: 74506
ClinVar
Submissions by phenotype
not provided Benign:3
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Oct 01, 2023 | DNHD1: BP4, BS2 - |
DNHD1-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 30, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at